Streamlined out-of-the-box workflows
for a faster path to antiviral therapeutics

Boost your COVID-19 development and scale-up with new best practice workflows streamlined for antiviral therapeutics, designed to accelerate development, developability and diagnostics.

Time is of the essence. Adding streamlined workflows designed for biopharmaceutical development to your software toolbox is probably the easiest and fastest way to reduce time-to-market. Because tailored, best practice workflows will ensure more complete data capture with context – for faster strategic insight.Upgrade your current solution now, by deploying the IDBS Bioprocess Solution with new workflows for antiviral therapeutics to record high-quality, contextualized data – at the moment it is acquired.

New streamlined workflows available now for:


  • Improve your cell expansion, track lineage and develop efficient high-quality cell lines
  • Optimize bioreactor runs based on critical data capture
  • Refine your harvesting using collective multiple-process data
  • Speed up your downstream processes, with best practice workflows for chromatography, buffer control, and filtration


  • Evaluate your therapeutic candidates faster with pertinent workflows to support purity, fragmentation, charge heterogeneity, aggregation, immunogenicity, thermostability, efficacy and manufacturability.


  • Monitor your diagnostic efforts with a well-structured plate-based workflow designed to assess pro-inflammatory immune responses like cytokine storms.

Right now, we offer free use of our software et fast deployment – and our full support – to anyone working toward COVID-19 therapeutics.

Demander une démonstration